NEWS: 公告在東京證券交易所JASDAQ標準市場新上市

表紙
市場調查報告書

抗凝固拮抗劑的全球市場:產品類型,各流通管道的市場規模,佔有率及趨勢分析,各市場區隔預測(2020年∼2027年)

Anticoagulant Reversal Drugs Market Size, Share & Trends Analysis Report By Product Type (Prothrombin Complex Concentrates, Phytonadione, Andexanet Alfa, Idarucizumab, Protamine), By Distribution Channel, And Segment Forecasts, 2020 - 2027

出版商 Grand View Research, Inc. 商品編碼 989738
出版日期 內容資訊 英文 110 Pages
商品交期: 2-10個工作天內
價格
抗凝固拮抗劑的全球市場:產品類型,各流通管道的市場規模,佔有率及趨勢分析,各市場區隔預測(2020年∼2027年) Anticoagulant Reversal Drugs Market Size, Share & Trends Analysis Report By Product Type (Prothrombin Complex Concentrates, Phytonadione, Andexanet Alfa, Idarucizumab, Protamine), By Distribution Channel, And Segment Forecasts, 2020 - 2027
出版日期: 2021年02月12日內容資訊: 英文 110 Pages
簡介

全球抗凝固拮抗劑的市場規模在2020年∼2027年間,預測將以14.3%的年複合成長率擴大,到2027年達到18億1,000萬美元。。出血性疾病的增加,新藥的引進以及需要抗凝治療的病例數的增加是預計在預測期內推動市場增長的因素。

本報告提供全球抗凝固拮抗劑市場相關調查分析,提供市場及產業預測,各市場區隔·各地區的預測,加上競爭情形相關的系統性資訊。

目錄

第1章 調查方法與範圍

第2章 摘要整理

第3章 抗凝固拮抗劑市場變數,趨勢及範圍

  • 市場系統預測
  • 滲透與成長預測的製圖
  • 市場動態
  • 抗凝固拮抗劑市場分析工具

第4章 抗凝固拮抗劑市場-競爭分析

  • 主要的市場參與者最新趨勢影響分析
  • 業者情勢
    • 主要的經銷商和流通管道合作夥伴的清單
  • 公開企業
    • 企業的市場情況分析
    • 競爭的儀表板分析
  • 非公開企業
    • 主要的新興企業的清單
    • 地區網路地圖
    • 企業的市場情況分析

第5章 抗凝固拮抗劑市場:各產品類型市場估計·趨勢分析

  • 定義和範圍
  • 各產品類型市場佔有率分析,2019年及2027年
  • 市場區隔儀表板
  • 全球抗凝固拮抗劑市場,產品類型,2016年∼2027年
  • 市場規模與預測及趨勢分析,2016年∼2027年
    • 凝血酶原複合物濃縮物
    • 苯乙二酮
    • Andexanet Alfa
    • Idarucizumab
    • 魚精蛋白
    • 其他

第6章 抗凝固拮抗劑市場:各流通管道市場估計·趨勢分析

  • 定義和範圍
  • 各流通管道市場佔有率分析,2019年及2027年
  • 市場區隔儀表板
  • 全球抗凝固拮抗劑市場,各流通管道,2016年∼2027年
  • 市場規模與預測及趨勢分析,2016年∼2027年
    • 醫院藥局
    • 零售藥局
    • 線上藥局

第7章 抗凝固拮抗劑市場:各地區市場的估計·趨勢分析

  • 地區市場概述
  • 各地區市場佔有率和主要企業,2019年
    • 北美
    • 歐洲
    • 南美
    • 亞太地區
    • 中東·非洲
  • 各國市場佔有率分析,2019年
    • 北美
    • 歐洲
    • 南美
    • 亞太地區
    • 中東·非洲
  • 要因別的SWOT分析(政治及法律,經濟及技術性)
    • 北美
    • 歐洲
    • 南美
    • 亞太地區
    • 中東·非洲
  • 市場規模與預測,及趨勢分析,2019年∼2027年
    • 北美
    • 歐洲
    • 南美
    • 亞太地區
    • 中東·非洲

第8章 企業簡介

  • 企業簡介
目錄
Product Code: GVR-4-68039-293-5

Anticoagulant Reversal Drugs Market Growth & Trends

The global anticoagulant reversal drugs market size is expected to reach USD 1.81 billion by 2027, according to a new report by Grand View Research, Inc. It is expected to expand at a CAGR of 14.3% from 2020 to 2027. The rising number of bleeding disorders, the introduction of new drugs, and the growing number of cases requiring anticoagulant therapies are some of the factors anticipated to foster market growth during the forecast period.

In October 2015, Praxbind (idarucizumab) by Boehringer Ingelheim Pharmaceuticals was approved as an anticoagulant reversal drug indicated for patients treated with Pradaxa (dabigatran) during emergency surgery or uncontrolled or life-threatening bleeding. Hence, the availability of these anticoagulation reversal drugs allows doctors and patients to consider such treatment options with greater confidence, therefore boosting the demand for anticoagulant reversal drugs.

Bleeding disorders like hemophilia can be acquired or inherited. However, other bleeding disorders can occur from conditions, such as HIV, anemia, leukemia, cirrhosis of the liver, and vitamin K deficiency. According to the National Heart, Lung, and Blood Institute, more than 3 million people in the U.S. are affected with anemia, which is the most common blood disorder. The Leukemia & Lymphoma Society (LLS) stated that in the year 2020, the number of people expected to be diagnosed with leukemia is around 60,530. A rise in bleeding disorders is increasing the demand for anticoagulants, thus fueling the market growth.

However, the high cost of these reversal therapies is anticipated to restrain the market growth. As per the American College of Cardiology, 4-F PCC (Kcentra) helps in treating bleeding cases caused by rivaroxaban and apixaban and it is dosed at 50 units/kg. Its average wholesale price is USD 2.90 per unit, therefore treating a patient whose weight is 100 kg would cost around USD 14,500.

Anticoagulant Reversal Drugs Market Report Highlights

  • By product type, idarucizumab held the largest share in 2019 as it is currently approved in many countries, including the U.S., Europe, Canada, and Australia. Andexanet alfa is expected to witness lucrative growth over the forecast period owing to its approval and launch in key markets
  • Based on distribution channel, in 2019, the hospital pharmacy segment accounted for the largest share due to increased preference for hospital settings to treat the emergency cases during uncontrolled bleeding
  • North America dominated the market in 2019 due to the high affordability and easy availability of such costly drugs in the U.S.
  • The Asia Pacific market is expected to witness the fastest growth over the forecast period owing to the increasing awareness about bleeding disorders in emerging economies, such as India and China
  • The annual cost of treating 10 to 20 patients with idarucizumab ranges from USD 34,825 to USD 69,650, respectively with a single 5 g dose, thus hindering its demand in under-developed countries

Table of Contents

Chapter 1 Methodology and Scope

  • 1.1 Market segmentation & scope
  • 1.2 Market definition
  • 1.3 Information procurement
    • 1.3.1 Purchased database
    • 1.3.2 GVR's internal database
    • 1.3.3 Secondary sources & third party perspectives
    • 1.3.4 Primary research
  • 1.4 Information analysis
    • 1.4.1 Data analysis models
  • 1.5 Market formulation & data visualization
  • 1.6 Data validation & publishing

Chapter 2 Executive Summary

  • 2.1 Market Outlook
  • 2.2 Segment Outlook
  • 2.3 Competitive Insights

Chapter 3 Anticoagulant Reversal Drugs Market Variables, Trends & Scope

  • 3.1 Market Lineage Outlook
    • 3.1.1 Parent Market Outlook
    • 3.1.2 Ancillary Market Outlook
  • 3.2 Penetration and Growth Prospect Mapping
  • 3.3 Market Dynamics
    • 3.3.1 Market driver analysis
      • 3.3.1.1 Approval and launch of novel drugs
      • 3.3.1.2 Increasing prevalence of bleeding disorders
      • 3.3.1.3 Rise in incidence of indications for anticoagulant therapy
    • 3.3.2 Market Restraint Analysis
      • 3.3.2.1 High cost of reversal therapies
    • 3.3.3 Industry challenges
  • 3.4 Anticoagulant Reversal Drugs Market Analysis Tools
    • 3.4.1 Industry analysis - Porter's
      • 3.4.1.1 Supplier Power
      • 3.4.1.2 Buyer Power
      • 3.4.1.3 Substitution Threat
      • 3.4.1.4 Threat from new entrants
      • 3.4.1.5 Competitive Rivalry
    • 3.4.2 PESTEL Analysis
      • 3.4.2.1 Political Landscape
      • 3.4.2.2 Environmental Landscape
      • 3.4.2.3 Social landscape
      • 3.4.2.4 Application landscape
      • 3.4.2.5 Legal Landscape

Chapter 4 Anticoagulant Reversal Drugs Market - Competitive Analysis

  • 4.1 Recent Developments & Impact Analysis, by Key Market Participants
  • 4.2 Vendor Landscape
    • 4.2.1 List of key distributors and channel partners
    • 4.2.2 Key company market share analysis, 2019
  • 4.3 Public Companies
    • 4.3.1 Company market position analysis
    • 4.3.2 Competitive dashboard analysis
  • 4.4 Private Companies
    • 4.4.1 List of key emerging companies
    • 4.4.2 Regional network map
    • 4.4.3 Company market position analysis

Chapter 5 Anticoagulant Reversal Drugs Market: Product Type Estimates And Trend Analysis

  • 5.1 Definition & Scope
  • 5.2 Product Type Market Share Analysis, 2019 & 2027
  • 5.3 Segment Dashboard
  • 5.4 Global Anticoagulant Reversal Drugs Market, by Product Type, 2016 to 2027
  • 5.5 Market Size & Forecasts and Trend Analyses, 2016 to 2027
    • 5.5.1 Prothrombin Complex Concentrates
      • 5.5.1.1 Prothrombin Complex Concentrates Market Estimates and Forecasts, 2016 to 2027 (USD Million)
    • 5.5.2 Phytonadione
      • 5.5.2.1 Phytonadione Market Estimates and Forecasts, 2016 to 2027 (USD Million)
    • 5.5.3 Andexanet Alfa
      • 5.5.3.1 Andexanet Alfa Market Estimates and Forecasts, 2016 to 2027 (USD Million)
    • 5.5.4 Idarucizumab
      • 5.5.4.1 Idarucizumab Market Estimates and Forecasts, 2016 to 2027 (USD Million)
    • 5.5.5 Protamine
      • 5.5.5.1 Protamine Market Estimates and Forecasts, 2016 to 2027 (USD Million)
    • 5.5.6 Others
      • 5.5.6.1 Others Market Estimates and Forecasts, 2016 to 2027 (USD Million)

Chapter 6 Anticoagulant Reversal Drugs Market: Distribution Channel Estimates And Trend Analysis

  • 6.1 Definition & Scope
  • 6.2 Distribution Channel Market Share Analysis, 2019 & 2027
  • 6.3 Segment Dashboard
  • 6.4 Global Anticoagulant Reversal Drugs Market, by Distribution Channel, 2016 to 2027
  • 6.5 Market Size & Forecasts and Trend Analyses, 2016 to 2027
    • 6.5.1 Hospital Pharmacy
      • 6.5.1.1 Hospital Pharmacy Market Estimates and Forecasts, 2016 to 2027 (USD Million)
    • 6.5.2 Retail Pharmacy
      • 6.5.2.1 Retail Pharmacy Market Estimates and Forecasts, 2016 to 2027 (USD Million)
    • 6.5.3 Online Pharmacy
      • 6.5.3.1 Online Pharmacy Market Estimates and Forecasts, 2016 to 2027 (USD Million)

Chapter 7 Anticoagulant Reversal Drugs Market: Regional Estimates & Trend Analysis

  • 7.1 Regional Market Snapshot
  • 7.2 Regional Market Share and Leading Players, 2019
    • 7.2.1 North America
    • 7.2.2 Europe
    • 7.2.3 Latin America
    • 7.2.4 Asia Pacific
    • 7.2.5 Middle East & Africa
  • 7.3 Market Share Analysis by Country, 2019
    • 7.3.1 North America
      • 7.3.1.1 U.S.
      • 7.3.1.2 Canada
    • 7.3.2 Europe
      • 7.3.2.1 U.K.
      • 7.3.2.2 Germany
      • 7.3.2.3 Spain
      • 7.3.2.4 France
      • 7.3.2.5 Italy
      • 7.3.2.6 Russia
    • 7.3.3 Latin America
      • 7.3.3.1 Brazil
      • 7.3.3.2 Mexico
      • 7.3.3.3 Argentina
    • 7.3.4 Asia Pacific
      • 7.3.4.1 Japan
      • 7.3.4.2 China
      • 7.3.4.3 India
      • 7.3.4.4 South Korea
      • 7.3.4.5 Singapore
      • 7.3.4.6 Australia
    • 7.3.5 Middle East & Africa
      • 7.3.5.1 South Africa
      • 7.3.5.2 Saudi Arabia
      • 7.3.5.3 UAE
  • 7.4 SWOT Analysis, by Factor (Political & Legal, Economic and Technological)
    • 7.4.1 North America
    • 7.4.2 Europe
    • 7.4.3 Latin America
    • 7.4.4 Asia Pacific
    • 7.4.5 Middle East & Africa
  • 7.5 Market Size & Forecasts, and Trend Analysis, 2019 to 2027
    • 7.5.1 North America
      • 7.5.1.1 North America Market Size & Forecasts and Trend Analysis, 2016 to 2027 (USD Million)
      • 7.5.1.2 U.S.
      • 7.5.1.2.1 U.S. Market Size & Forecasts and Trend Analysis, By Product Type, 2016 to 2027 (USD million)
      • 7.5.1.2.2 U.S. Market Size & Forecasts and Trend Analysis, By Distribution Channel, 2016 to 2027 (USD million)
      • 7.5.1.3 Canada
      • 7.5.1.3.1 Canada Market Size & Forecasts and Trend Analysis, By Product Type, 2016 to 2027 (USD million)
      • 7.5.1.3.2 Canada Market Size & Forecasts and Trend Analysis, By Distribution Channel, 2016 to 2027 (USD million)
    • 7.5.2 Europe
      • 7.5.2.1 Europe Market Size & Forecasts and Trend Analysis, 2016 to 2027 (USD Million)
      • 7.5.2.2 U.K.
      • 7.5.2.2.1 U.K. Market Size & Forecasts and Trend Analysis, By Product Type, 2016 to 2027 (USD million)
      • 7.5.2.2.2 U.K. Market Size & Forecasts and Trend Analysis, By Distribution Channel, 2016 to 2027 (USD million)
      • 7.5.2.3 Germany
      • 7.5.2.3.1 Germany Market Size & Forecasts and Trend Analysis, By Product Type, 2016 to 2027 (USD million)
      • 7.5.2.3.2 Germany Market Size & Forecasts and Trend Analysis, By Distribution Channel, 2016 to 2027 (USD million)
      • 7.5.2.4 Spain
      • 7.5.2.4.1 Spain Market Size & Forecasts and Trend Analysis, By Product Type, 2016 to 2027 (USD million)
      • 7.5.2.4.2 Spain Market Size & Forecasts and Trend Analysis, By Distribution Channel, 2016 to 2027 (USD million)
      • 7.5.2.5 France
      • 7.5.2.5.1 France Market Size & Forecasts and Trend Analysis, By Product Type, 2016 to 2027 (USD million)
      • 7.5.2.5.2 France Market Size & Forecasts and Trend Analysis, By Distribution Channel, 2016 to 2027 (USD million)
      • 7.5.2.6 Italy
      • 7.5.2.6.1 Italy Market Size & Forecasts and Trend Analysis, By Product Type, 2016 to 2027 (USD million)
      • 7.5.2.6.2 Italy Market Size & Forecasts and Trend Analysis, By Distribution Channel, 2016 to 2027 (USD million)
      • 7.5.2.7 Russia
      • 7.5.2.7.1 Russia Market Size & Forecasts and Trend Analysis, By Product Type, 2016 to 2027 (USD million)
      • 7.5.2.7.2 Russia Market Size & Forecasts and Trend Analysis, By Distribution Channel, 2016 to 2027 (USD million)
    • 7.5.3 Latin America
      • 7.5.3.1 Latin America Market Size & Forecasts and Trend Analysis, 2016 to 2027 (USD Million)
      • 7.5.3.2 Brazil
      • 7.5.3.2.1 Brazil Market Size & Forecasts and Trend Analysis, By Product Type, 2016 to 2027 (USD million)
      • 7.5.3.2.2 Brazil Market Size & Forecasts and Trend Analysis, By Distribution Channel, 2016 to 2027 (USD million)
      • 7.5.3.3 Mexico
      • 7.5.3.3.1 Mexico Market Size & Forecasts and Trend Analysis, By Product Type, 2016 to 2027 (USD million)
      • 7.5.3.3.2 Mexico Market Size & Forecasts and Trend Analysis, By Distribution Channel, 2016 to 2027 (USD million)
      • 7.5.3.4 Argentina
      • 7.5.3.4.1 Argentina Market Size & Forecasts and Trend Analysis, By Product Type, 2016 to 2027 (USD million)
      • 7.5.3.4.2 Argentina Market Size & Forecasts and Trend Analysis, By Distribution Channel, 2016 to 2027 (USD million)
    • 7.5.4 Asia Pacific
      • 7.5.4.1 Asia Pacific Market Size & Forecasts and Trend Analysis, 2016 to 2027 (USD Million)
      • 7.5.4.2 Japan
      • 7.5.4.2.1 Japan Market Size & Forecasts and Trend Analysis, By Product Type, 2016 to 2027 (USD million)
      • 7.5.4.2.2 Japan Market Size & Forecasts and Trend Analysis, By Distribution Channel, 2016 to 2027 (USD million)
      • 7.5.4.3 China
      • 7.5.4.3.1 China Market Size & Forecasts and Trend Analysis, By Product Type, 2016 to 2027 (USD million)
      • 7.5.4.3.2 China Market Size & Forecasts and Trend Analysis, By Distribution Channel, 2016 to 2027 (USD million)
      • 7.5.4.4 India
      • 7.5.4.4.1 India Market Size & Forecasts and Trend Analysis, By Product Type, 2016 to 2027 (USD million)
      • 7.5.4.4.2 India Market Size & Forecasts and Trend Analysis, By Distribution Channel, 2016 to 2027 (USD million)
      • 7.5.4.5 South Korea
      • 7.5.4.5.1 South Korea Market Size & Forecasts and Trend Analysis, By Product Type, 2016 to 2027 (USD million)
      • 7.5.4.5.2 South Korea Market Size & Forecasts and Trend Analysis, By Distribution Channel, 2016 to 2027 (USD million)
      • 7.5.4.6 Singapore
      • 7.5.4.6.1 Singapore Market Size & Forecasts and Trend Analysis, By Product Type, 2016 to 2027 (USD million)
      • 7.5.4.6.2 Singapore Market Size & Forecasts and Trend Analysis, By Distribution Channel, 2016 to 2027 (USD million)
      • 7.5.4.7 Australia
      • 7.5.4.7.1 Australia Market Size & Forecasts and Trend Analysis, By Product Type, 2016 to 2027 (USD million)
      • 7.5.4.7.2 Australia Market Size & Forecasts and Trend Analysis, By Distribution Channel, 2016 to 2027 (USD million)
    • 7.5.5 Middle East & Africa
      • 7.5.5.1 Middle East & Africa Market Size & Forecasts and Trend Analysis, 2016 to 2027 (USD Million)
      • 7.5.5.2 South Africa
      • 7.5.5.2.1 South Africa Market Size & Forecasts and Trend Analysis, By Product Type, 2016 to 2027 (USD million)
      • 7.5.5.2.2 South Africa Market Size & Forecasts and Trend Analysis, By Distribution Channel, 2016 to 2027 (USD million)
      • 7.5.5.3 Saudi Arabia
      • 7.5.5.3.1 Saudi Arabia Market Size & Forecasts and Trend Analysis, By Product Type, 2016 to 2027 (USD million)
      • 7.5.5.3.2 Saudi Arabia Market Size & Forecasts and Trend Analysis, By Distribution Channel, 2016 to 2027 (USD million)
      • 7.5.5.4 UAE
      • 7.5.5.4.1 UAE Market Size & Forecasts and Trend Analysis, By Product Type, 2016 to 2027 (USD million)
      • 7.5.5.4.2 UAE Market Size & Forecasts and Trend Analysis, By Distribution Channel, 2016 to 2027 (USD million)

Chapter 8 COMPANY PROFILE

  • 8.1 Company Profiles
    • 8.1.1 Portola Pharmaceuticals
      • 8.1.1.1 Company overview
      • 8.1.1.2 Financial Performance
      • 8.1.1.3 Product benchmarking
      • 8.1.1.4 Strategic initiatives
    • 8.1.2 Boehringer Ingelheim
      • 8.1.2.1 Company overview
      • 8.1.2.2 Financial Performance
      • 8.1.2.3 Product benchmarking
      • 8.1.2.4 Strategic initiatives
    • 8.1.3 CSL Behring
      • 8.1.3.1 Company overview
      • 8.1.3.2 Financial Performance
      • 8.1.3.3 Product benchmarking
      • 8.1.3.4 Strategic initiatives
    • 8.1.4 Bausch Health Companies Inc.
      • 8.1.4.1 Company overview
      • 8.1.4.2 Financial Performance
      • 8.1.4.3 Product benchmarking
      • 8.1.4.4 Strategic initiatives
    • 8.1.5 Octapharma AG
      • 8.1.5.1 Company overview
      • 8.1.5.2 Financial Performance
      • 8.1.5.3 Product benchmarking
      • 8.1.5.4 Strategic initiatives
    • 8.1.6 Dr. Reddy's Laboratories
      • 8.1.6.1 Company overview
      • 8.1.6.2 Financial Performance
      • 8.1.6.3 Product benchmarking
      • 8.1.6.4 Strategic initiatives
    • 8.1.7 AMAG Pharmaceuticals, Inc.
      • 8.1.7.1 Company overview
      • 8.1.7.2 Financial Performance
      • 8.1.7.3 Product benchmarking
      • 8.1.7.4 Strategic initiatives
    • 8.1.8 Pfizer, Inc.
      • 8.1.8.1 Company overview
      • 8.1.8.2 Financial Performance
      • 8.1.8.3 Product benchmarking
      • 8.1.8.4 Strategic initiatives
    • 8.1.9 SGPharma Pvt. Ltd.
      • 8.1.9.1 Company overview
      • 8.1.9.2 Financial Performance
      • 8.1.9.3 Product benchmarking
      • 8.1.9.4 Strategic initiatives
    • 8.1.10 Alps Pharmaceutical Ind. Co., Ltd.
      • 8.1.10.1 Company overview
      • 8.1.10.2 Financial Performance
      • 8.1.10.3 Product benchmarking
      • 8.1.10.4 Strategic initiatives
    • 8.1.11 Fresenius Kabi AG
      • 8.1.11.1 Company overview
      • 8.1.11.2 Financial Performance
      • 8.1.11.3 Product benchmarking
      • 8.1.11.4 Strategic initiatives

List of Tables

  • Table 1 List of key distributors and channel partners
  • Table 2 List of key emerging companies'/technology disruptors/innovators
  • Table 3 North America anticoagulant reversal drugs market, by country, 2016 - 2027 (USD Million)
  • Table 4 North America anticoagulant reversal drugs market, by product type, 2016 - 2027 (USD Million)
  • Table 5 North America anticoagulant reversal drugs market, by distribution channel, 2016 - 2027 (USD Million)
  • Table 6 U.S. anticoagulant reversal drugs market, by product type, 2016 - 2027 (USD Million)
  • Table 7 U.S. anticoagulant reversal drugs market, by distribution channel, 2016 - 2027 (USD Million)
  • Table 8 Canada anticoagulant reversal drugs market, by product type, 2016 - 2027 (USD Million)
  • Table 9 Canada anticoagulant reversal drugs market, by distribution channel, 2016 - 2027 (USD Million)
  • Table 10 Europe anticoagulant reversal drugs market, by country, 2016 - 2027 (USD Million)
  • Table 11 Europe anticoagulant reversal drugs market, by product type, 2016 - 2027 (USD Million)
  • Table 12 Europe anticoagulant reversal drugs market, by distribution channel, 2016 - 2027 (USD Million)
  • Table 13 Germany anticoagulant reversal drugs market, by product type, 2016 - 2027 (USD Million)
  • Table 14 Germany anticoagulant reversal drugs market, by distribution channel, 2016 - 2027 (USD Million)
  • Table 15 U.K. anticoagulant reversal drugs market, by product type, 2016 - 2027 (USD Million)
  • Table 16 U.K. anticoagulant reversal drugs market, by distribution channel, 2016 - 2027 (USD Million)
  • Table 17 France anticoagulant reversal drugs market, by product type, 2016 - 2027 (USD Million)
  • Table 18 France anticoagulant reversal drugs market, by distribution channel, 2016 - 2027 (USD Million)
  • Table 19 Italy anticoagulant reversal drugs market, by product type, 2016 - 2027 (USD Million)
  • Table 20 Italy anticoagulant reversal drugs market, by distribution channel, 2016 - 2027 (USD Million)
  • Table 21 Spain anticoagulant reversal drugs market, by product type, 2016 - 2027 (USD Million)
  • Table 22 Spain anticoagulant reversal drugs market, by distribution channel, 2016 - 2027 (USD Million)
  • Table 23 Russia anticoagulant reversal drugs market, by product type, 2016 - 2027 (USD Million)
  • Table 24 Russia anticoagulant reversal drugs market, by distribution channel, 2016 - 2027 (USD Million)
  • Table 25 Asia Pacific anticoagulant reversal drugs market, by country, 2016 - 2027 (USD Million)
  • Table 26 Asia Pacific anticoagulant reversal drugs market, by product type, 2016 - 2027 (USD Million)
  • Table 27 Asia Pacific anticoagulant reversal drugs market, by distribution channel, 2016 - 2027 (USD Million)
  • Table 28 Japan anticoagulant reversal drugs market, by product type, 2016 - 2027 (USD Million)
  • Table 29 Japan anticoagulant reversal drugs market, by distribution channel, 2016 - 2027 (USD Million)
  • Table 30 China anticoagulant reversal drugs market, by product type, 2016 - 2027 (USD Million)
  • Table 31 China anticoagulant reversal drugs market, by distribution channel, 2016 - 2027 (USD Million)
  • Table 32 India anticoagulant reversal drugs market, by product type, 2016 - 2027 (USD Million)
  • Table 33 India anticoagulant reversal drugs market, by distribution channel, 2016 - 2027 (USD Million)
  • Table 34 Australia anticoagulant reversal drugs market, by product type, 2016 - 2027 (USD Million)
  • Table 35 Australia anticoagulant reversal drugs market, by distribution channel, 2016 - 2027 (USD Million)
  • Table 36 South Korea anticoagulant reversal drugs market, by product type, 2016 - 2027 (USD Million)
  • Table 37 South Korea anticoagulant reversal drugs market, by distribution channel, 2016 - 2027 (USD Million)
  • Table 38 Singapore anticoagulant reversal drugs market, by product type, 2016 - 2027 (USD Million)
  • Table 39 Singapore anticoagulant reversal drugs market, by distribution channel, 2016 - 2027 (USD Million)
  • Table 40 Latin America anticoagulant reversal drugs market, by country, 2016 - 2027 (USD Million)
  • Table 41 Latin America anticoagulant reversal drugs market, by product type, 2016 - 2027 (USD Million)
  • Table 42 Latin America anticoagulant reversal drugs market, by distribution channel, 2016 - 2027 (USD Million)
  • Table 43 Brazil anticoagulant reversal drugs market, by product type, 2016 - 2027 (USD Million)
  • Table 44 Brazil anticoagulant reversal drugs market, by distribution channel, 2016 - 2027 (USD Million)
  • Table 45 Mexico anticoagulant reversal drugs market, by product type, 2016 - 2027 (USD Million)
  • Table 46 Mexico anticoagulant reversal drugs market, by distribution channel, 2016 - 2027 (USD Million)
  • Table 47 Argentina anticoagulant reversal drugs market, by product type, 2016 - 2027 (USD Million)
  • Table 48 Argentina anticoagulant reversal drugs market, by distribution channel, 2016 - 2027 (USD Million)
  • Table 49 MEA anticoagulant reversal drugs market, by country, 2016 - 2027 (USD Million)
  • Table 50 MEA anticoagulant reversal drugs market, by product type, 2016 - 2027 (USD Million)
  • Table 51 MEA anticoagulant reversal drugs market, by distribution channel, 2016 - 2027 (USD Million)
  • Table 52 South Africa anticoagulant reversal drugs market, by product type, 2016 - 2027 (USD Million)
  • Table 53 South Africa anticoagulant reversal drugs market, by distribution channel, 2016 - 2027 (USD Million)
  • Table 54 Saudi Arabia anticoagulant reversal drugs market, by product type, 2016 - 2027 (USD Million)
  • Table 55 Saudi Arabia anticoagulant reversal drugs market, by distribution channel, 2016 - 2027 (USD Million)
  • Table 56 UAE anticoagulant reversal drugs market, by product type, 2016 - 2027 (USD Million)
  • Table 57 UAE anticoagulant reversal drugs market, by distribution channel, 2016 - 2027 (USD Million)

List of Figures

  • Fig. 1 Anticoagulant reversal drugs market segmentation
  • Fig. 2 Market research process
  • Fig. 3 Information procurement
  • Fig. 4 Primary research pattern
  • Fig. 5 Market research approaches
  • Fig. 6 Anticoagulant reversal drugs market snapshot (2019)
  • Fig. 7 Anticoagulant reversal drugs market: Segment snapshot (2019)
  • Fig. 8 Competitive Insights (2019)
  • Fig. 9 Parent market outlook
  • Fig. 10 Related/ancillary market outlook
  • Fig. 11 Penetration and growth prospect mapping
  • Fig. 12 Anticoagulant reversal drugs market driver impact
  • Fig. 13 Anticoagulant reversal drugs market restraint impact
  • Fig. 14 Anticoagulant reversal drugs industry challenges
  • Fig. 15 Porter's Five Forces Analysis
  • Fig. 16 SWOT Analysis, By Factor (Political & legal Economic and technological)
  • Fig. 17 Strategic alliance analysis
  • Fig. 18 Recent developments & impact analysis, by key market participants
  • Fig. 19 Key company market share analysis, 2019
  • Fig. 20 Company market position analysis
  • Fig. 21 Definition and scope, by product type
  • Fig. 22 Product Type market share analysis, 2019 & 2027
  • Fig. 23 Segment dashboard
  • Fig. 24 Global anticoagulant reversal drugs market, by product type, 2016 - 2027 (USD Million)
  • Fig. 25 Prothrombin complex concentrates market size & forecasts and trend analysis, 2016 to 2027 (USD Million)
  • Fig. 26 Phytonadione market size & forecasts and trend analysis, 2016 to 2027 (USD Million)
  • Fig. 27 Andexanet alfa market size & forecasts and trend analysis, 2016 to 2027 (USD Million)
  • Fig. 28 Idarucizumab market size & forecasts and trend analysis, 2016 to 2027 (USD Million)
  • Fig. 29 Protamine market size & forecasts and trend analysis, 2016 to 2027 (USD Million)
  • Fig. 30 Others market size & forecasts and trend analysis, 2016 to 2027 (USD Million)
  • Fig. 31 Definition and scope, by distribution channel
  • Fig. 32 Distribution channel market share analysis, 2019 & 2027
  • Fig. 33 Segment dashboard
  • Fig. 34 Global anticoagulant reversal drugs market, by distribution channel, 2016-2027 (USD Million)
  • Fig. 35 Hospital pharmacy market size & forecasts and trend analysis, 2016 to 2027 (USD Million)
  • Fig. 36 Retail pharmacy market size & forecasts and trend analysis, 2016 to 2027 (USD Million)
  • Fig. 37 Online pharmacy market size & forecasts and trend analysis, 2016 to 2027 (USD Million)
  • Fig. 38 Anticoagulant reversal drugs market: Snapshot, 2019
  • Fig. 39 North America anticoagulant reversal drugs market share and leading players, 2019
  • Fig. 40 Europe anticoagulant reversal drugs market share and leading players, 2019
  • Fig. 41 Asia Pacific anticoagulant reversal drugs market share and leading players, 2019
  • Fig. 42 Latin America anticoagulant reversal drugs market share and leading players, 2019
  • Fig. 43 Middle East and Africa anticoagulant reversal drugs market share and leading players, 2019
  • Fig. 44 North America market share analysis by country, 2019
  • Fig. 45 Europe market share analysis by country, 2019
  • Fig. 46 Asia Pacific market share analysis by country, 2019
  • Fig. 47 Latin America market share analysis by country, 2019
  • Fig. 48 Middle East and Africa market share analysis by country, 2019
  • Fig. 49 North America SWOT analysis, by factor (political & legal, economic and technological)
  • Fig. 50 Europe SWOT analysis, by factor (political & legal, economic and technological)
  • Fig. 51 Asia Pacific SWOT analysis, by factor (political & legal, economic and technological)
  • Fig. 52 Latin America SWOT analysis, by factor (political & legal, economic and technological)
  • Fig. 53 Middle East and Africa SWOT analysis, by factor (political & legal, economic and technological)
  • Fig. 54 North America market size, & forecasts and trend analysis, 2016 to 2027 (USD Million)
  • Fig. 55 U.S. market size, & forecasts and trend analysis, 2016 to 2027 (USD Million)
  • Fig. 56 Canada market size, & forecasts and trend analysis, 2016 to 2027 (USD Million)
  • Fig. 57 Europe market size, & forecasts and trend analysis, 2016 to 2027 (USD Million)
  • Fig. 58 U.K. market size, & forecasts and trend analysis, 2016 to 2027 (USD Million)
  • Fig. 59 Germany market size, & forecasts and trend analysis, 2016 to 2027 (USD Million)
  • Fig. 60 Spain market size, & forecasts and trend analysis, 2016 to 2027 (USD Million)
  • Fig. 61 France market size, & forecasts and trend analysis, 2016 to 2027 (USD Million)
  • Fig. 62 Italy market size, & forecasts and trend analysis, 2016 to 2027 (USD Million)
  • Fig. 63 Russia market size, & forecasts and trend analysis, 2016 to 2027 (USD Million)
  • Fig. 64 Asia Pacific market size, & forecasts and trend analysis, 2016 to 2027 (USD Million)
  • Fig. 65 China market size, & forecasts and trend analysis, 2016 to 2027 (USD Million)
  • Fig. 66 Japan market size, & forecasts and trend analysis, 2016 to 2027 (USD Million)
  • Fig. 67 India market size, & forecasts and trend analysis, 2016 to 2027 (USD Million)
  • Fig. 68 Australia market size, & forecasts and trend analysis, 2016 to 2027 (USD Million)
  • Fig. 69 South Korea market size, & forecasts and trend analysis, 2016 to 2027 (USD Million)
  • Fig. 70 Singapore market size, & forecasts and trend analysis, 2016 to 2027 (USD Million)
  • Fig. 71 Latin America market size, & forecasts and trend analysis, 2016 to 2027 (USD Million)
  • Fig. 72 Brazil market size, & forecasts and trend analysis, 2016 to 2027 (USD Million)
  • Fig. 73 Mexico market size, & forecasts and trend analysis, 2016 to 2027 (USD Million)
  • Fig. 74 Argentina market size, & forecasts and trend analysis, 2016 to 2027 (USD Million))
  • Fig. 75 Middle East and Africa market size, & forecasts and trend analysis, 2016 to 2027 (USD Million)
  • Fig. 76 South Africa market size, & forecasts and trend analysis, 2016 to 2027 (USD Million)
  • Fig. 77 Saudi Arabia market size, & forecasts and trend analysis, 2016 to 2027 (USD Million)
  • Fig. 78 UAE market size, & forecasts and trend analysis, 2016 to 2027 (USD Million)